Search Filters
Advanced Search
SMC ID Date Medicine Submission Type Indication
SMC2517 09/10/2023 lutetium (177Lu) vipivotide tetraxetan (Pluvicto) Full

Treatment of adult patients with prostate-specific membrane antigen (PSMA)-positive metastatic castration-resistant prostate cancer (mCRPC) who have been treated with androgen receptor (AR) pathway inhibition and taxane-based chemotherapy or who are not medically suitable for taxanes.
735/11 12/12/2016 cabazitaxel (Jevtana) Resubmission Cabazitaxel in combination with prednisone or prednisolone is indicated for the treatment of adult patients with hormone refractory metastatic prostate cancer previously treated with a docetaxel-containing regimen.

No medicines have been found.